Radient Technologies EBITDA margin
What is the EBITDA margin of Radient Technologies?
The EBITDA margin of Radient Technologies, Inc. is -133.64%
What is the definition of EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin of companies in the Industrials sector on TSXV compared to Radient Technologies
What does Radient Technologies do?
Radient Technologies Inc., together with its subsidiaries, processes, sells, and distributes cannabis materials in Canada. It offers cannabis oil, standardized cannabinoid ingredients, cannabis extracts, and cannabis formulations. The company also provides extraction services for the extraction, purification, and isolation of cannabinoids for third parties. Its ingredients are used in natural food and beverage products, personal care products, and nutraceutical and pharmaceutical products. Radient Technologies Inc. was incorporated in 2001 and is headquartered in Edmonton, Canada.
Companies with ebitda margin similar to Radient Technologies
- ContextLogic has EBITDA margin of -134.80%
- Outset Medical has EBITDA margin of -134.68%
- Nanoco Plc has EBITDA margin of -134.13%
- Majedie Investments Plc has EBITDA margin of -134.11%
- Bryah Resources has EBITDA margin of -133.96%
- Puhui Wealth Investment Management Co has EBITDA margin of -133.96%
- Radient Technologies has EBITDA margin of -133.64%
- BNY Mellon High Yield Strategies Fund has EBITDA margin of -133.54%
- HTC Purenergy has EBITDA margin of -133.47%
- HTC Purenergy has EBITDA margin of -133.47%
- Vivoryon Therapeutics AG has EBITDA margin of -133.43%
- Vivoryon Therapeutics AG has EBITDA margin of -133.43%
- Vivoryon Therapeutics N.V has EBITDA margin of -133.43%